l carnitine intramuscular or subcutaneous Injections L-Carnitine Injection (Intramuscular): How It

Discussion We demonstrated that the observed inability of 6-day-old seedlings to tolerate the identical water deficit compared to 4-day-old seedlings is associated with a disturbance in cellular redox homeostasis and the reduced and oxidized ascorbate and glutathione pools

COVID-19 severity is related to poor executive function in people with post-COVID conditions

the therapeutic agent is selected from an siRNA, a microRNA, an antisense oligonucleotide, and a plasmid capable of expressing an siRNA, a microRNA, or an antisense oligonucleotide the siRNA, microRNA, or antisense RNA comprises a polynucleo the present invention includes a method of treating a disease or disorder characterized by underexpression of a polypeptide in a subject, comprising providing to the subject the pharmaceutical composition of the present invention, wherein the therapeutic agent is a plasmid that encodes the polypeptide or a functional variant or fragment thereof

Foda AM, Ibrahim SS, Ibrahim SM, Elbaz EM